Kommentar der Deutschen Gesellschaft für Thorax-, Herz- und Gefäßchirurgie zum Positionspapier der DGK - Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation (TAVI)

Abstract

Surgical aortic valve replacement is still considered the first-line treatment for patients suffering from severe aortic valve stenosis. In recent years, transcatheter aortic valve implantation (TAVI) has emerged as an alternative for selected high-risk patients. According to the latest results of the German external quality assurance program, mandatory by law, the initially very high mortality and procedural morbidity have now decreased to approximately 6 and 12%, respectively. Especially in Germany, the number of patients treated by TAVI has increased exponentially. In 2013, a total of 10.602 TAVI procedures were performed. TAVI is claimed to be minimally invasive. This is true concerning the access, but it does not describe the genuine complexity of the procedure, defined by the close neighborhood of the aortic valve to delicate intracardiac structures. Hence, significant numbers of life-threatening complications may occur and have been reported. Owing to the complexity of TAVI, there is a unanimous concordance between cardiologists and cardiac surgeons in the Western world demanding a close heart team approach for patient selection, intervention, handling of complications, and pre- as well as postprocedural care, respectively. The prerequisite is that TAVI should not be performed in centers with no cardiac surgery on site. This is emphasized in all international joint guidelines and expert consensus statements. Today, a small number of patients undergo TAVI procedures in German hospitals without a department of cardiac surgery on site. To be noted, most of these hospitals perform less than 20 cases per year. Recently, the German Cardiac Society (DGK) published a position paper supporting this practice pattern. Contrary to this statement and concerned about the safety of patients treated this way, the German Society for Thoracic and Cardiovascular Surgery (DGTHG) still fully endorses the European (ESC/EACTS) and other actual international guidelines and consensus statements. Only the concomitance of departments for cardiac surgery and cardiology on site can provide optimal TAVI care. This commentary by the DGTHG delineates the data and resources upon which its opinion is based.

Keywords

aortic valve and root - database - heart valve - transapical - percutaneous - TAVI - outcomes - practice guidelines - professional affairs

• Literaturverzeichnis

• 1 Cribier A, Eltchaninoff H, Bash A , et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106: 3006-3008
• 2 Blumenstein J, Kempfert J, Van Linden A , et al. First-in-man evaluation of the transapical APICA ASC™ access and closure device: the initial 10 patients. Eur J Cardiothorac Surg 2013; 44 (6) 1057-1062 , discussion 1062
• 3 Qualitätsreport AQUA. 2013 www.sqg.de (accessed October 20, 2014)
• 4 Figulla HR, Cremer J, Walther T , et al. Positionspapier zur kathetergeführten Aortenklappenintervention. Kardiologe 2009; 3: 199-206
• 5 Kuck K-H, Eggebrecht H, Figulla HR , et al. Positionspapier der Deutschen Gesellschaft für Kardiologie – Qualitätskriterien zur Durchführung der transvaskulären Aortenklappenimplantation. Kardiologe 2014; 8 DOI: 10.1007/s12181-014-0622-8
• 6 Smith CR, Leon MB, Mack MJ , et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 2011; 364 (23) 2187-2198
• 7 Leon MB, Smith CR, Mack M , et al; PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363 (17) 1597-1607
• 8 Adams DH, Popma JJ, Reardon MJ , et al; U.S. Core Valve Clinical Investigators. Transcatheter aortic-valve replacement with a self-expanding prosthesis. N Engl J Med 2014; 370 (19) 1790-1798
• 9 Abdel-Wahab M, Mehilli J, Frerker C , et al; CHOICE investigators. Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 2014; 311 (15) 1503-1514
• 10 Toggweiler S, Humphries KH, Lee M , et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 2013; 61 (4) 413-419
• 11 Beckmann A, Hamm C, Figulla HR , et al; GARY Executive Board. The German Aortic Valve Registry (GARY): a nationwide registry for patients undergoing invasive therapy for severe aortic valve stenosis. Thorac Cardiovasc Surg 2012; 60 (5) 319-325
• 12 Hamm CW, Möllmann H, Holzhey D , et al; GARY-Executive Board. The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J 2014; 35 (24) 1588-1598
• 13 Mohr FW, Holzhey D, Möllmann H , et al; GARY Executive Board. The German Aortic Valve Registry: 1-year results from 13 680 patients with aortic valve disease. Eur J Cardiothorac Surg 2014; 46 (5) 808-816
• 14 Zahn R, Gerckens U, Grube E , et al; German Transcatheter Aortic Valve Interventions-Registry Investigators. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry. Eur Heart J 2011; 32 (2) 198-204
• 15 Sherif MA, Zahn R, Gerckens U , et al. Effect of gender differences on 1-year mortality after transcatheter aortic valve implantation for severe aortic stenosis: results from a multicenter real-world registry. Clin Res Cardiol 2014; 103 (8) 613-620
• 16 Cuttone F, Ivascau C, Grollier G, Massetti M. Distal embolization of Edwards SAPIEN prosthesis during transcatheter aortic valve implantation. G Chir 2013; 34 (9-10) 275-277
• 17 Schramm R, Mair H, Becker C , et al. Partial inferior sternotomy and deep hypothermic circulatory arrest for rescue of a failed TAVI case: what does constitute 'inoperable'?. Thorac Cardiovasc Surg 2013; 61 (5) 431-434
• 18 Hein R, Abdel-Wahab M, Sievert H , et al; German Transcatheter Aortic Valve Interventions Registry Investigators. Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery. EuroIntervention 2013; 9 (4) 446-451
• 19 Tay EL, Gurvitch R, Wijeysinghe N , et al. Outcome of patients after transcatheter aortic valve embolization. JACC Cardiovasc Interv 2011; 4 (2) 228-234
• 20 Lange R, Bleiziffer S, Piazza N , et al. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients. Eur J Cardiothorac Surg 2011; 40 (5) 1105-1113
• 21 Seiffert M, Conradi L, Baldus S , et al. Severe intraprocedural complications after transcatheter aortic valve implantation: calling for a heart team approach. Eur J Cardiothorac Surg 2013; 44 (3) 478-484 , discussion 484
• 22 Aminian A, Lalmand J, El Nakadi B. Perforation of the descending thoracic aorta during transcatheter aortic valve implantation (TAVI): an unexpected and dramatic procedural complication. Catheter Cardiovasc Interv 2011; 77 (7) 1076-1078
• 23 Gerber RT, Osborn M, Mikhail GW. Delayed mortality from aortic dissection post transcatheter aortic valve implantation (TAVI): the tip of the iceberg. Catheter Cardiovasc Interv 2010; 76 (2) 202-204
• 24 Généreux P, Head SJ, Wood DA , et al. Transcatheter aortic valve implantation 10-year anniversary: review of current evidence and clinical implications. Eur Heart J 2012; 33 (19) 2388-2398
• 25 Wendler O, Dworakowski R. TAVI in patients unsuitable for surgery: a prognostic benefit for all?. J Am Coll Cardiol 2014; 63 (9) 912-913
• 26 Mylotte D, Andalib A, Thériault-Lauzier P , et al. Transcatheter heart valve failure: a systematic review. Eur Heart J 2014; pii: ehu388 (Epub ahead of print)
• 27 Vahanian A, Alfieri O, Andreotti F , et al; Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guideline on the management of valvular heart disease (version 2012). Eur Heart J 2012; 33 (19) 2451-2496
• 28 Webb J, Rodés-Cabau J, Fremes S , et al. Transcatheter aortic valve implantation: a Canadian Cardiovascular Society position statement. Can J Cardiol 2012; 28 (5) 520-528
• 29 Nishimura RA, Otto CM, Bonow RO , et al; American College of Cardiology/American Heart Association Task Force on Practice Guidelines. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2014; 63 (22) 2438-2488
• 30 Tommaso CL, Bolman III RM, Feldman T , et al. Multisociety (AATS, ACCF, SCAI, and STS) expert consensus statement: operator and institutional requirements for transcatheter valve repair and replacement, part 1: transcatheter aortic valve replacement. J Am Coll Cardiol 2012; 59 (22) 2028-2042
• 31 Position Statement for the Operator and Institutional Requirements for a Transcatheter Aortic Valve Implantation (TAVI) program. http://www.csanz.edu.au/resources/position-statements/ (accessed October 20, 2014)
• 32 Mylotte D, Head SJ, Kappetein AP, Piazza N. TAVI at institutions without cardiovascular surgery departments: why?. EuroIntervention 2014; 10 (5) 539-541
• 33 Beckmann A, Beyersdorf F, Diegeler A , et al. Basisstandards einer Fachabteilung für Herzchirurgie. Qualitätsanforderungen für die Versorgung von herzkranken Patientinnen und Patienten im Zusammenhang mit Operationen/Eingriffen am Herzen, den herznahen Gefäßen und der thorakalen Organtransplantation. Thorac Cardiovasc Surg 2013; 61 (8) 651-655